Awiqli Injection, Solution
Product Images NDC 0169-3121

Product Visual Gallery

This gallery contains 28 technical images submitted to the FDA as part of the official labeling for Awiqli (NDC 0169-3121). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novo Nordisk, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton_3ml (Carton 3ml)

Awiqli FlexTouch (insulin icodec-abae) injection 700 units/mL (U-700) prefilled pen packaging label. The carton includes one 3 mL pen and 13 disposable needles, with instructions for single-patient use only, subcutaneous injection, and once weekly dosing. Manufactured by Novo Nordisk.*

FDA Label Image

Carton_sample_1ml (Carton Sample 1ml)

The image shows the packaging label for Awiqli FlexTouch (insulin icodec-abae) injection, 700 units/mL (U-700) strength. It is a subcutaneous injection in a 1 mL prefilled pen with 9 disposable needles included. The label highlights single-patient use, weekly dosing, and pen dose increments of 10 units by Novo Nordisk.*

FDA Label Image

Example (Example)

An instructional illustration showing a close-up of a dose counter on an injection device. The dose counter window displays numbers 60 and 80, with a pointer set between them. The example text explains that for a needed dose of 100 units, the dose counter stops at 70 units, indicating how to read or use the device dose counter.*

FDA Label Image

Figure_1 (Figure 1)

Chemical structure diagram of insulin icodec-abae, showing the amino acid sequence and molecular bonds for the peptide chain and side chains. The depiction includes detailed atomic connections and labeling for the B29 lysine modification associated with the molecule.*

FDA Label Image

Figure_2 (Figure 2)

A line graph depicting glucose infusion rate (mg/kg/min) on the y-axis versus time in days on the x-axis, showing fluctuations in glucose infusion rate over a 7-day period. The graph includes a solid black trend line with a shaded area indicating variability around the data points.*

FDA Label Image

Figure_i (Figure I)

An instructional illustration showing how to hold and operate an Awiqli injection pen. The image depicts a hand gripping the pen's body and using the thumb to push a part of the pen downward, with an arrow pointing upward indicating an injection step, designed for subcutaneous use of insulin icodec-abae 700 U/mL solution.*

FDA Label Image

Figure_l (Figure L)

An instructional illustration showing a hand holding a pen-style injection device labeled with '80' on its dose window. The device is positioned vertically with the needle end down, indicating insertion into the skin for a subcutaneous injection. A downward arrow beside the thumb suggests applying pressure or pressing down on the top of the device.*

FDA Label Image

Figure_a (Figure A)

An instructional illustration showing a close-up of two hands holding a green injection pen, with an arrow indicating the direction of movement along the pen. It likely demonstrates how to operate or prepare the injection device for use.*

FDA Label Image

Figure_b (Figure B)

An instructional diagram showing a hand holding a pen-style injection device, likely for subcutaneous administration of medication. The device is dark-colored with a window or display section. The image highlights the grip and positioning of the device for injection use.*

FDA Label Image

Figure_c (Figure C)

Illustration depicting a component of a medical device or injection system, featuring a cap-like part with a knurled edge and an adjacent blue arrow pointing left, likely indicating a removal or attachment direction.*

FDA Label Image

Figure_d (Figure D)

Illustration showing a hand holding a green and white injector pen with an arrow indicating a twisting motion on a cap or component of the pen, likely demonstrating part of the device preparation or use for the Awiqli insulin icodec-abae injection pen.*

FDA Label Image

Figure_e (Figure E)

An instructional illustration showing a hand removing a protective cap from the needle end of an injection pen device. An arrow indicates the direction to pull the cap off, likely for preparing the device for subcutaneous injection.*

FDA Label Image

Figure_f (Figure F)

An instructional illustration showing a hand removing the protective cap from the tip of a pen injector device, indicated by an arrow pointing away from the device tip. The illustration focuses on preparing the device for use, commonly associated with subcutaneous injection preparations.*

FDA Label Image

Figure_g (Figure G)

An instructional illustration showing a hand holding an insulin injection pen with a dosage window displaying numbers, alongside an arrow indicating the direction to turn the dial for setting the dose.*

FDA Label Image

Figure_h (Figure H)

An instructional illustration showing hands adjusting a dose selector on an injection pen device for Awiqli (insulin icodec-abae) 700 U/mL. The dose window displays '10 units selected' with an arrow indicating the user turning the dial to set the dose.*

FDA Label Image

Figure_j (Figure J)

Illustration showing a hand turning the dose selector on an Awiqli injection pen for subcutaneous use. The dose window displays numeric values, and an arrow indicates the direction to rotate the dial for dose adjustment.*

FDA Label Image

Figure_k (Figure K)

Instructional illustration showing a dosing selector for Awiqli insulin icodec-abae injection, solution. The image displays two close-up views of the dose dial: one indicating 70 units selected and the other showing 270 units selected. This visual aids users in setting the correct insulin dose.*

FDA Label Image

Figure_m (Figure M)

Instructional illustration showing the proper hand positioning for using the Awiqli injection pen (Insulin icodec-abae 700 U/mL). The image highlights how to hold the pen with one hand and includes a close-up inset demonstrating counting slowly from 1 to 6 during the injection process.*

FDA Label Image

Figure_n (Figure N)

Illustration showing the tip of a green injection pen with a needle attached, featuring a blue upward-pointing arrow beside it. The image likely depicts an aspect of the injection device for Awiqli (Insulin icodec-abae) 700 U/mL solution for subcutaneous injection by Novo Nordisk.*

FDA Label Image

Figure_o (Figure O)

An instructional illustration showing a hand twisting the cap of an injection pen device, indicated by a curved arrow pointing clockwise. The device appears to be related to the Awiqli insulin icodec-abae 700 U/mL subcutaneous injection pen.*

FDA Label Image

Figure_p (Figure P)

An instructional illustration showing a cap being placed onto or removed from a container with a septum or membrane-like top featuring radial slits. The diagram includes a downward-pointing blue arrow indicating the direction of the cap placement.*

FDA Label Image

Figure_q (Figure Q)

An instructional illustration showing a close-up of a hand holding and positioning a cap or component near the top of a pen-style injector device, likely demonstrating a step in preparing or assembling the injection pen for use.*

FDA Label Image

Figure_r (Figure R)

An illustration showing the assembly of a component onto the tip of a device, featuring two blue arrows indicating the direction to attach a white, ridged cap to a green cylindrical syringe or pen injector, likely related to the use of Awiqli (insulin icodec-abae) injection.*

FDA Label Image

Carton_1-5ml (Image 01)

Awiqli FlexTouch injection packaging label for insulin icodec-abae 700 units/mL (U-700). The label indicates it is a prefilled pen containing 1 x 1.5 mL dose with 13 disposable needles. It is for subcutaneous use, single-patient use only, and delivers doses in 10 unit increments. The label includes branding for Novo Nordisk and instructions to use a new needle for every injection.*

FDA Label Image

Use_1_time_each_week (Image 02)

A blue rectangular label with white text stating the dosing frequency: '1 time each week'. This label likely indicates the recommended administration schedule for the medication.*

FDA Label Image

Pen_image (Image 03)

Illustration of the Awiqli FlexTouch injection pen, showing labeled components: pen cap, pen window, expiration date and lot number on the back of the pen label, dose counter with dose pointer, dose selector, and dose button. The pen is designed for subcutaneous injection of insulin icodec-abae.*

FDA Label Image

Needle_and_cap (Image 04)

An instructional diagram showing four labeled components of a needle assembly: outer needle cap, inner needle cap, needle, and paper tab. Each component is displayed separately in sequence from left to right.*

FDA Label Image

Injection_site (Injection Site)

Illustration showing proper subcutaneous injection sites on a human figure, highlighting the upper arms, stomach, and upper legs as recommended areas for administration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.